BioCentury
ARTICLE | Clinical News

Arbutus Biopharma preclinical data

October 12, 2015 7:00 AM UTC

In a mouse model of HBV infection, 4 weekly doses of 0.3 mg/kg TKM-HBV reduced HBV covalently closed circular DNA levels by 42% vs. untreated control animals. This quarter, Arbutus expects data from a...